间充质干细胞移植干预2-OA/BSA诱导的原发性胆汁性胆管炎小鼠肝内胆管上皮细胞自噬蛋白表达的变化

doi:10.3969/j.issn.1672-5069.2019.03.007

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (3): 337-340.doi: 10.3969/j.issn.1672-5069.2019.03.007

间充质干细胞移植干预2-OA/BSA诱导的原发性胆汁性胆管炎小鼠肝内胆管上皮细胞自噬蛋白表达的变化

朱赟, 姚根宏, 唐小军

210008 南京市南京大学医学院附属鼓楼医院风湿免疫科

收稿日期:2018-07-13 出版日期:2019-05-10 发布日期:2019-05-15
通讯作者: 唐小军,E-mail: xjtang09@163.com
作者简介:朱赟,女,38岁,医学博士,副主任医师。主要从事免疫性肝病诊治研究。E-mail:zhuyunjs@126.com
基金资助:
*国家自然科学基金资助项目（编号：81401348）; “十三五”南京市卫生青年人才培养工程计划项目（编号：QRX17040）

Mesenchymal stem cell transplantation alleviating hepatic injury by modulating intrahepatic biliary epithelial cell autophagic flux in mice with 2-OA-BSA-induced primary biliary cholangitis

Zhu Yun, Yao Genhong, Tang Xiaojun

Department of Rheumatology and Immunology,Affiliated Drum Tower Hospital,Nanjing University Medical School,Nanjing 210008,Jiangsu Province,China

Received:2018-07-13 Online:2019-05-10 Published:2019-05-15
Contact: Corresponding author:Zhu Yun,E-mail:zhuyunjs@126.com

摘要/Abstract

摘要： 目的观察异基因间充质干细胞（MSCs）移植干预原发性胆汁性胆管炎（PBC）小鼠对肝内胆管上皮细胞（IBECs）自噬的调控作用及其分子机制。方法将30只C57BL/6小鼠随机分为模型组（n=18）、BSA组（n=6）和未处理组（n=6）。采用2-辛炔酸结合牛血清白蛋白（2-OA-BSA）注射诱导PBC模型。再将PBC模型小鼠随机分为模型组（PBC组,n=4）、MSCs移植干预组（MSCs组,n=6）和转录激活因子3（STAT3）抑制剂干预组（Stattic组,n=6）。采用灌流法分离肝内胆管树纯化IBECs,采用WB法检测IBECs组织STAT3/pSTAT3、p62、LC3、PKR/pPKR、Beclin-1蛋白、eIF2α/peIF2α、LAMP-1表达,采用RT-PCR法检测STAT3、LC3和p62-mRNA,使用电镜观察IBECs内自噬泡形成。结果模型组肝组织汇管区淋巴细胞浸润并有散在的肉芽肿形成,而MSCs和Stattic干预组小鼠汇管区炎性细胞浸润减少;模型组小鼠IBECs自噬蛋白Beclin-1、STAT3和pSTAT3表达较BSA组增强,而MSCs移植和Stattic干预组上述蛋白表达减弱;模型组和MSCs组p62 mRNA水平较BSA组下降,模型组STAT3 mRNA水平较BSA组下降。结论我们成功建立了2-OA-BSA诱导的PBC小鼠模型,MSCs移植干预通过下调STAT3表达减轻了PBC小鼠肝组织汇管区损害,可能与调控小鼠体内自噬相关蛋白表达有关。

关键词: 原发性胆汁性胆管炎, 间充质干细胞, 自噬, STAT3信号通路

Abstract: Objectiv To establish a reliable animal model of primary biliary cholangitis（PBC） and to investigate the therapeutic effect of umbilical cord-derived mesenchymal stem cells （UC-MSC） on STAT3 signal in intrahepatic biliary epithelial cells（IBECs） of this PBC animal. Methods C57BL/6 mice were intraperitoneally injected with 2-octynyl acid （2-OA）-bovine serum albumin （BSA） adjuvanted with Freund's adjuvant/incomplete Freund's adjuvant （CFA/IFA） or with same amount of BSA adjuvanted with IFA,or untreated as control. The model mice 22 weeks later were randomly divided into model （n=4）,MSCs transplantation （n=6） and STAT3 inhibitors-treated group（n=6）. The intrahepatic biliary tree and IBECs were obtained,and STAT3/pSTAT3,p62,LC3,PKR/pPKR,Beclin-1,eIF2α/peIF2α and LAMP-1 expression were detected by WB,and STAT3,LC3 and p62-mRNA were detected by RT-PCR. Results The lymphocyte infiltration and granuloma in portal area were found in liver tissues of model mice,while they were obviously alleviated in MSCs-or Stattic-intervened groups;the expressions of Beclin-1,STAT3 and pSTAT3 in IBECs from model intensified as compared to those in BSA-treated group,while they were weaken in MSCs-or Stattic-intervened groups;p62 mRNA levels decreased in model and MSC transplanted grous as compared to that in BSA-treated group,and STAT3 mRNA level in model decreased as compared to that in BSA-treated group. Conclusion Our findings indicate that MSC transplantation might regulate the autophagy and decrease the expression of STAT3 signals in mice with primary biliary cholangitis.

Key words: Primary biliary cholangitis, Mesenchymal stem cells, Autophagy, STAT3 signals

朱赟, 姚根宏, 唐小军. 间充质干细胞移植干预2-OA/BSA诱导的原发性胆汁性胆管炎小鼠肝内胆管上皮细胞自噬蛋白表达的变化[J]. 实用肝脏病杂志, 2019, 22(3): 337-340.

Zhu Yun, Yao Genhong, Tang Xiaojun. Mesenchymal stem cell transplantation alleviating hepatic injury by modulating intrahepatic biliary epithelial cell autophagic flux in mice with 2-OA-BSA-induced primary biliary cholangitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 337-340.

参考文献

[1] Yamagiwa S,Kamimura H,Takamura M,et al.Autoantibodies in primary biliary cirrhosis:recent progress in research on the pathogenetic and clinical significance. World J Gastroenterol,2014,20(10):2606-2612.
[2] Hirschfield GM,Gershwin ME.The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol,2013,8:303-330.
[3] Bowlus CL,Gershwin ME.The diagnosis of primary biliary cirrhosis. Autoimmun Rev,2014,13(4-5):441-444.
[4] Wakabayashi K,Lian ZX,Leung PS,et al.Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology,2008,48(2):531-540.
[5] Rieger R,Leung PS,Jeddeloh MR,et al.Identification of 2-nonynoic acid,a cosmetic component,as a potential trigger of primary biliary cirrhosis. J Autoimmun,2006,27(1):7-16. [6] 胡建武,卢胜明,车路平,等.10种常见SPF级实验大小鼠血液学及生化指标正常参考值的探讨.实验动物科学,2007,24(2):5-10.
[7] Wang L,Han Q,Chen H,et al.Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells Dev,2014,23(20):2482-2489.
[8] Wang L,Li J,Liu H,et al.A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol,2013,28(1):85-92.
[9] Ludwig J,Dickson ER,McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).Virchows Arch A Pathol Anat Histol,1978,379:103-112.
[10] Szczepanek K,Lesnefsky EJ,Larner AC.Multi-tasking:nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol,2012,22(8):429-437.
[11] Al Zaid Siddiquee K,Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res,2008,18(2):254-267.
[12] Kisseleva T,Bhattacharya S,Braunstein J,et al.Signaling through the JAK/STAT pathway,recent advances and future challenges. Gene,2002,285(1-2):1-24.
[13] O'Shea JJ,Gadina M,Schreiber RD. Cytokine signaling in2002:new surprises in the Jak/Stat pathway. Cell,2002,109 Suppl: 121-131.
[14] Gimeno R,Lee CK,Schindler C,et al.Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes. Mol Cell Biol,2005,25(13):5456-5465.
[15] Debonera F1,Aldeguer X,Shen X,et al. Activation of interleukin-6/STAT 3 and liver regeneration following transplantation. J Surg Res,2001,96(2):289-295.
[16] Liu Z,Sakamoto T,Yokomuro S,et al.Acute obstructive cholangiopathy in interleukin-6 deficient mice:compensation by leukemia inhibitory factor(LIF)suggests importance of gp-130 signaling in the ductular reaction. Liver,2000,20(2):114-124.
[17] Lehle K,Birnbaum DE,Preuner JG.Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place. Transplant Proc,2005,37(1):159-161.

间充质干细胞移植干预2-OA/BSA诱导的原发性胆汁性胆管炎小鼠肝内胆管上皮细胞自噬蛋白表达的变化

Mesenchymal stem cell transplantation alleviating hepatic injury by modulating intrahepatic biliary epithelial cell autophagic flux in mice with 2-OA-BSA-induced primary biliary cholangitis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	任俞霏, 陈小青, 孔维宗, 王迎春. 丹酚酸B对非酒精性脂肪性肝病细胞模型自噬功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 804-807.
[2]	高磊, 曹蕾, 王瑞芳, 冯丹丹, 薛娟. 人脐带间充质干细胞移植对酒精性肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 812-815.
[3]	李琪, 曾阿娟, 孟雯, 张海英, 李雪梅. 原发性胆汁性胆管炎患者胆囊病变临床分析[J]. 实用肝脏病杂志, 2019, 22(6): 924-927.
[4]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.
[5]	边新渠, 陈杰, 刘燕敏, 黄云丽, 任美欣, 张小丹, 杜晓菲, 黄春洋, 廖慧钰, 单晶, 韩莹. 熊去氧胆酸治疗原发性胆汁性胆管炎患者血清甲状腺激素水平变化*[J]. 实用肝脏病杂志, 2019, 22(5): 716-719.
[6]	张骏飞, 许何明, 宋海燕, 董静, 潘劲劲, 陈照林, 徐军, 陈从新, 刘波. 自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征：巴黎标准诊断中国患者灵敏度低[J]. 实用肝脏病杂志, 2019, 22(4): 537-540.
[7]	张骏飞, 宋海燕, 陈曦, 潘劲劲, 刘力伟, 陈从新, 刘波. 多次人脐带间充质干细胞移植治疗失代偿期乙型肝炎肝硬化患者临床研究[J]. 实用肝脏病杂志, 2018, 21(5): 693-696.
[8]	佟辉, 李涛, 申川, 彭承宏, 邱伟华, 沈柏用, 祝哲诚. let-7a调控自噬对缺氧状态下原发性肝癌HCCLM3细胞增殖的影响^*[J]. 实用肝脏病杂志, 2018, 21(5): 701-704.
[9]	赵宇, 祝瑜, 张代忠. 人脐带间充质干细胞肝内移植联合苦参素治疗失代偿期乙型肝炎肝硬化患者疗效与转归分析[J]. 实用肝脏病杂志, 2018, 21(3): 360-363.
[10]	张永婷, 朱传龙, 李军, 章莉莉. c-Met基因过表达脐带间充质干细胞株的构建*[J]. 实用肝脏病杂志, 2018, 21(3): 397-400.
[11]	焦栓林, 赵晓蕊, 欧阳洪, 杜世奇, 秦建增, 王全楚. 自体骨髓间充质干细胞联合促肝细胞生长素治疗失代偿期酒精性肝硬化疗效分析[J]. 实用肝脏病杂志, 2017, 20(6): 773-774.
[12]	文良志, 熊吉, 孙文静, 陈东风. 肝硬化与骨髓造血[J]. 实用肝脏病杂志, 2017, 20(4): 391-393.
[13]	孙文静, 刘凯军, 文良志, 陈东风. 骨髓间充质干细胞对肝脏的影响[J]. 实用肝脏病杂志, 2017, 20(4): 394-396.
[14]	沈建坤，郑联坵，潘兴南，赖江琼. 自体骨髓间充质干细胞治疗失代偿期酒精性肝硬化疗效分析^*[J]. 实用肝脏病杂志, 2015, 18(6): 628-632.
[15]	吕胜祥，乔晓，梁凤，王昌成，别小芹，甘建和. 脐带间充质干细胞治疗自身免疫性肝病患者疗效观察^*[J]. 实用肝脏病杂志, 2015, 18(5): 500-503.